Performance in initiating clinical research Q1 2015/16 – ID Research Name of Date of Date of Date of Duration Duration Duration Reasons for Ethics Trial Receipt of NHS First between between between Met delay Committee Valid Permission Patient VRA and NHS VRA and correspond Reference Research NHS First to: Number Application and Patient First Patient 50122 14/YH/006 GEM 02/09/2014 02/09/2014 yes 0 15 15 Yes FPFV Neither target met 50123 14/LO/088 OAK 03/09/2014 03/09/2014 yes 0 61 61 Yes 50124 13/MW/04 Mammo - 29/05/2014 20/06/2014 yes 22 15 37 Yes Delay due NHS provider 50 to approval of service support costs 50125 13/yh/028 24/03/2014 16/07/2014 no 114 No Selection Both Criteria has since been revised by sponsor to assist in 50126 14/NE/107 RELIEVE 1 17/02/2015 23/02/2015 no 6 Within 70 No Neither days patients suitable as per inclusion criteria 50128 ML1435 24/03/2015 30/03/2015 no 6 Within 70 Awaiting Sponsor Lung days trial drug on site
Performance in initiating clinical research – Q1 2015/16 ID Research Ethics Committee Reference Number Name of Trial Date of Receipt of Valid Research Application Date of NHS Permission Date of First Patient Duration between VRA and NHS Duration between NHS and First Patient Duration between VRA and First Patient Met Reasons for delay correspond to: 50122 14/YH/006 GEM 02/09/2014 02/09/2014 yes 0 15 15 Yes FPFV target met Neither 50123 14/LO/088 OAK 03/09/2014 03/09/2014 yes 0 61 61 Yes 50124 13/MW/04 Mammo - 50 29/05/2014 20/06/2014 yes 22 15 37 Yes Delay due to approval of service support costs NHS provider 50125 13/yh/028 24/03/2014 16/07/2014 no 114 No Selection Criteria has since been revised by sponsor to assist in Both 50126 14/NE/107 RELIEVE 1 17/02/2015 23/02/2015 no 6 Within 70 days No patients suitable as per inclusion criteria Neither 50128 ML1435 Lung 24/03/2015 30/03/2015 no 6 Within 70 days Awaiting trial drug on site Sponsor
research-a1.docx